ZA981609B - Method of treating a tumor - Google Patents

Method of treating a tumor

Info

Publication number
ZA981609B
ZA981609B ZA981609A ZA981609A ZA981609B ZA 981609 B ZA981609 B ZA 981609B ZA 981609 A ZA981609 A ZA 981609A ZA 981609 A ZA981609 A ZA 981609A ZA 981609 B ZA981609 B ZA 981609B
Authority
ZA
South Africa
Prior art keywords
mammal
administering
effective amount
tumor
treating
Prior art date
Application number
ZA981609A
Other languages
English (en)
Inventor
Daniel L Dexter
Paul E Juniewicz
James B Rake
Daniel D Van Hoff
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of ZA981609B publication Critical patent/ZA981609B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA981609A 1997-03-07 1998-02-26 Method of treating a tumor ZA981609B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81476997A 1997-03-07 1997-03-07

Publications (1)

Publication Number Publication Date
ZA981609B true ZA981609B (en) 1998-12-08

Family

ID=25215967

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981609A ZA981609B (en) 1997-03-07 1998-02-26 Method of treating a tumor

Country Status (15)

Country Link
US (2) US6063780A (pt)
EP (1) EP1014990B1 (pt)
JP (1) JP2001513110A (pt)
AT (1) ATE338553T1 (pt)
AU (1) AU6178198A (pt)
BR (1) BR9808221A (pt)
CA (1) CA2281807C (pt)
DE (1) DE69835824T2 (pt)
DK (1) DK1014990T3 (pt)
ES (1) ES2268764T3 (pt)
HR (1) HRP980095A2 (pt)
NO (1) NO324974B1 (pt)
PT (1) PT1014990E (pt)
WO (1) WO1998039009A1 (pt)
ZA (1) ZA981609B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1014990E (pt) * 1997-03-07 2006-11-30 Sanofi Aventis Us Llc Associação antitumoral de 1, 4-dióxido de 3-amino-1,2,4-benzotriazina/paclitaxel/platina.
ATE218337T1 (de) * 1998-10-14 2002-06-15 Debiopharm Sa Verpackung eines oxaliplatinhaltigen arzneimittels
DE19925211B4 (de) * 1999-06-01 2006-01-12 PBS Pharmaceutical Bulk Substances SA Kit zur Herstellung einer Formulierung von Paclitaxel
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
KR100688217B1 (ko) * 1999-08-30 2007-02-28 데비오 팜 소시에떼 아노님 비경구 투여용의 약학적으로 안정된 옥살리백금 약학제제 및 그 조제방법
EP1341555A2 (fr) 2000-12-12 2003-09-10 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US20040127435A1 (en) * 2002-08-02 2004-07-01 Regents Of The University Of California Uses for inhibitors of inosine monophosphate dehydrogenase
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7989490B2 (en) * 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) * 2004-08-31 2006-12-07 Borek Zaludek Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
JP2009510165A (ja) * 2005-10-03 2009-03-12 ジェネティックス ファーマシューティカルズ， インク． 低酸素細胞を選択的に枯渇させるための方法
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en) 2007-03-16 2011-09-27 The United States Of America As Represented By The Secretary Of The Army High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
CN102026634B (zh) 2008-04-10 2014-01-22 弗吉尼亚州立邦联大学 诱导肿瘤缺氧以治疗癌症
US9278124B2 (en) 2012-10-16 2016-03-08 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
EP4201403A1 (en) * 2021-12-21 2023-06-28 Som Innovation Biotech, S.L. Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
PT1014990E (pt) * 1997-03-07 2006-11-30 Sanofi Aventis Us Llc Associação antitumoral de 1, 4-dióxido de 3-amino-1,2,4-benzotriazina/paclitaxel/platina.

Also Published As

Publication number Publication date
EP1014990A1 (en) 2000-07-05
NO994330D0 (no) 1999-09-06
NO994330L (no) 1999-10-25
AU6178198A (en) 1998-09-22
PT1014990E (pt) 2006-11-30
DK1014990T3 (da) 2006-12-11
CA2281807C (en) 2007-10-16
ATE338553T1 (de) 2006-09-15
DE69835824T2 (de) 2007-03-29
WO1998039009A1 (en) 1998-09-11
US6063780A (en) 2000-05-16
EP1014990B1 (en) 2006-09-06
ES2268764T3 (es) 2007-03-16
EP1014990A4 (en) 2004-03-24
HRP980095A2 (en) 1998-12-31
NO324974B1 (no) 2008-01-14
DE69835824D1 (de) 2006-10-19
BR9808221A (pt) 2000-05-16
JP2001513110A (ja) 2001-08-28
US6319923B1 (en) 2001-11-20
CA2281807A1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
ZA981609B (en) Method of treating a tumor
AU747599C (en) Antitumor agents
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
CY2473B1 (en) New phenanthridines.
PT880350E (pt) Tratamento de esclerose multipla
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
EP0902789A4 (pt)
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
CA2408541A1 (en) Treating eczema and/or psoriasis
WO1998030585A3 (en) Use of pea3 in tumor suppression
ID24184A (id) Obat untuk perawatan disfungsi ereksi
AP1896A (en) The method of treating cancer
ATE243522T1 (de) Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
GB9626472D0 (en) New use of comt inhibitors
WO2000004153A3 (en) Repression of cell transformation with human pea3
DE69426986D1 (de) Behandlung von laminitis
RU94024337A (ru) Антиметастатическое средство
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
UA30460A (uk) Спосіб лікування системного аутоімунного захворювання
MX9602846A (es) Compuestos de vanadato para el tratamiento de desordenes proliferativos, metastasis, y tumores resistentes a los farmacos.